In vivo bio-imaging Mice were anesthetized and placed in a custom-made bed, which allowed stable and reproducible imaging of the legs. In vivo scanning was performed using the Optix MX-2 Optical Molecular Image System (Advanced Research Technologies, Montreal, Canada), which uses time domain optical imaging. In time domain optical imaging, short pulses of light driven by pulsed laser diodes are used to illuminate the organism under study and excite fluorescent molecules. Time-of-flight distribution enables depth and concentration to be uncoupled and fluorescence lifetime to be determined. For Katushka, excitation was performed with a 635-nm (LDH-P-635) pulsing laser and emission was detected with a 650 long pass filter, while excitation of GFP was performed with a 470-nm pulsing laser and emission was detected through a 525-nm band pass filter. The scan was performed over a Cartesian grid in prioritized raster fashion, and each scan took on average 5 min.
Data analysis Data analysis was performed using the Optiview 2.2 software (ART Advanced Research Technologies Inc., Canada) supplied with the ART Optix bioimager. The software is used for background subtraction, lifetime analysis of the fluorochromes, depth and concentration analysis, and generation of 3D images.
The temporal dispersion of fluorescent photons is measured by time-correlated single photon counting (TCSPC) after excitation of a fluorophore by laser pulse. Analysis of this temporal dispersion curve—the fluorescent temporal point spread function (TPSF)—is used to obtain information of the in vivo fluorophore depth, concentration, and lifetime. Based on the Optix machine settings, the user will be able measure temporal and spatial distribution of fluorophores in regions in tissue: the light intensity is measured as a function of arrival time in nanoseconds, where the signal from deeper tissues arrives later allowing the estimation of relative concentration difference.
Results
Efficiency of Katushka expression in muscles over time
Electrotransfer of 5 µg of pTurboFP635 (‘Katushka’) plasmid resulted in a large increase in the in vivo fluorescent intensity (mean peak value = 18,695 ± 5,242 NC, n = 8) from the transfected muscle (Fig. 1). The Katushka intensity peaked 1 week after electrotransfer, where after it leveled off and returned to background level within 4 weeks (Fig. 2). To examine the sensitivity of the in vivo analysis compared with ex vivo scans, the muscles were excised at 4 weeks and scanned. Even though Katushka expression could not be detected in vivo, residual Katushka expression was present in muscles when scanned ex vivo (Fig. 3).
Fig. 1 Time course of the intensity of Katushka expression in muscles after DNA electrotransfer. The left leg was transfected, while the right leg served as untreated control. The picture series was taken of the same mouse, but is representative of seven mice.
Fig. 2 Time course of a Katushka intensity (mean ± SD) and b Katushka lifetime (mean ± SD) in a scanning series of seven mice following DNA electrotransfer of 5 µg Katushka plasmid.
Fig. 3 Four weeks after DNA electrotransfer, the muscles were scanned in vivo (left image), and then excised and scanned ex vivo with the same settings (right image).
万物蓬勃的7月里迎来了2022年ANTOP奖的申报和评审工作。由岛津企业管理(中国)有限公司申报的“3CoinONE全新体验气袋进样器”ANTOP奖进入专家评审阶段。奖项名称:3CoinONE全新体验......
青岛青源峰达太赫兹科技有限公司研发团队在国际顶级期刊《TrendsinBiotechnology》(译名:《生物技术趋势》)在线发表题为“THzmedicalimaging:frominvitroto......
蛋白质作为构成人体组织器官的支架和主要物质,在人体生命活动中起着重要作用。蛋白质的相互作用能产生许多效应,如形成特异底物作用通道、生成新的结合位点、失活、作用底物专一性和动力学变化等,细胞的代谢、信号......
2021年9月9日,无锡臻和生物科技有限公司(以下简称“臻和科技”)与美国VyantBio公司签署TissueofOrigin®(以下简称“TOO®”)全球权益和ZL转让协议,全资收购这款唯一获FDA......
2021年7月20日,JournalofCellularPhysiology及JournalofCellularBiochemistry同时撤回了中国学者49篇文章。从2019年开始,Journalo......
安进宣布,美国FDA授予其在研firstinclass单抗bemarituzumab突破性疗法认定,与改良FOLFOX6化疗方案(亚叶酸钙、氟尿嘧啶和奥沙利铂)联用,一线治疗FGFR2b过表达和HER......
2007年,中国科学院金属研究所研究员张志东在英国《哲学杂志》(PhilosophicalMagazine)上发表论文,提出两个猜想,并在猜想基础上推定出三维伊辛模型的精确解。被《哲学杂志》审稿人评价......
磷酸甘油酸突变酶1(PGAM1)通过其代谢活性以及与其他蛋白质(例如α平滑肌肌动蛋白(ACTA2))的相互作用,在癌症代谢和肿瘤进展中起关键作用。变构调节被认为是发现针对PGAM1的高选择性和有效抑制......
2018年12月6日,来自圣迭戈的消息——Illumina公司(纳斯达克股票代码:ILMN)今天宣布推出新型高密度基因分型芯片Infinium™GlobalDiversityArray。这款芯片设计源......
《NatureChemicalBiology》杂志在线版一篇文章介绍,伊利诺斯州立大学JohnA.Gerlt博士率领的研究小组研制出一种新途径,能够确定氨基酸序列已知的蛋白的结构和功能。这是首次利用计......